All-cause mortality was numerically higher in the metformin group but did not reach statistical significance, 33 of 309 (10.6%) vs. 19 of 315 (6.0%); HR 1.57; (95% CI 0.89–2.78); p = 0.117 ( Table 2 and Figure 2 D). 3.4.
← all excerpts
Metformin Use and Clinical Outcomes in Very Elderly Patients with Type 2 Diabetes and Chronic Kidney Disease.
1
0.1170
0.1170